ES368396A1 - Propanolamine derivatives - Google Patents

Propanolamine derivatives

Info

Publication number
ES368396A1
ES368396A1 ES69368396A ES368396A ES368396A1 ES 368396 A1 ES368396 A1 ES 368396A1 ES 69368396 A ES69368396 A ES 69368396A ES 368396 A ES368396 A ES 368396A ES 368396 A1 ES368396 A1 ES 368396A1
Authority
ES
Spain
Prior art keywords
active
propanolamine derivatives
active ingredients
sympathicomimetics
adrenolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES69368396A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES368396A1 publication Critical patent/ES368396A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions comprise a racemic or optically active compound of the formula: (R=CN or Cg 3-6 alkynyloxy) or salt thereof in association with a carrier. The active ingredients possess *-adrenolytic and hypotensive activity. The compositions may contain other active ingredients, e.g. heart-active or circulation-active sympathicomimetics or coronary dilators.
ES69368396A 1967-06-15 1969-06-16 Propanolamine derivatives Expired ES368396A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967B0093025 DE1593782B2 (en) 1967-06-15 1967-06-15 1-NITRILOPHENOXY- 2- HYDROXY -3- TERT.BUTYLAMINOPROPANE, THE PROCESS FOR THEIR MANUFACTURING AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THESE

Publications (1)

Publication Number Publication Date
ES368396A1 true ES368396A1 (en) 1971-05-01

Family

ID=6986720

Family Applications (6)

Application Number Title Priority Date Filing Date
ES354823A Expired ES354823A1 (en) 1967-06-15 1968-06-08 Propanolamine derivatives
ES69368396A Expired ES368396A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives
ES368395A Expired ES368395A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives
ES368401A Expired ES368401A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives
ES368398A Expired ES368398A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives
ES368399A Expired ES368399A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES354823A Expired ES354823A1 (en) 1967-06-15 1968-06-08 Propanolamine derivatives

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES368395A Expired ES368395A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives
ES368401A Expired ES368401A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives
ES368398A Expired ES368398A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives
ES368399A Expired ES368399A1 (en) 1967-06-15 1969-06-16 Propanolamine derivatives

Country Status (17)

Country Link
JP (2) JPS51100B1 (en)
AT (8) AT289077B (en)
BE (1) BE716647A (en)
BG (6) BG15038A3 (en)
CH (1) CH495950A (en)
DE (1) DE1593782B2 (en)
DK (1) DK127059B (en)
ES (6) ES354823A1 (en)
FI (1) FI48922C (en)
FR (2) FR1583559A (en)
GB (1) GB1187546A (en)
IE (1) IE32373B1 (en)
IL (1) IL30181A (en)
MY (1) MY7300288A (en)
NL (2) NL6808196A (en)
SE (1) SE355571B (en)
YU (7) YU33777B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
JPS57125772U (en) * 1981-01-30 1982-08-05
DE3744371A1 (en) * 1987-12-29 1989-07-13 Jacobs Suchard Ag PACKAGING FOR CONFECTIONERY
DE4014252A1 (en) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed (-)-1-(4'-Amino-3'-cyanophenyl)-2-iso-propyl-amino-ethanol - for treating fatty degeneration, obstructive lung disorders, allergic bronchial asthma, spastic bronchitis and premature labour

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (en) * 1962-12-11

Also Published As

Publication number Publication date
JPS51100B1 (en) 1976-01-05
AT289077B (en) 1971-04-13
AT289081B (en) 1971-04-13
AT289082B (en) 1971-04-13
YU229474A (en) 1977-10-31
AT289067B (en) 1971-04-13
DE1593782B2 (en) 1976-09-09
YU35578B (en) 1981-04-30
YU229074A (en) 1977-10-31
DE1593782A1 (en) 1972-04-20
NL6808196A (en) 1968-12-16
YU229274A (en) 1977-10-31
BG15039A3 (en) 1975-12-15
FI48922B (en) 1974-10-31
MY7300288A (en) 1973-12-31
YU33779B (en) 1978-05-15
YU228874A (en) 1977-10-31
YU229174A (en) 1977-10-31
AT289076B (en) 1971-04-13
YU33778B (en) 1978-05-15
ES368401A1 (en) 1971-05-01
IL30181A0 (en) 1968-08-22
CH495950A (en) 1970-09-15
SE355571B (en) 1973-04-30
GB1187546A (en) 1970-04-08
YU33775B (en) 1978-05-15
IL30181A (en) 1972-01-27
YU33777B (en) 1978-05-15
DK127059B (en) 1973-09-17
FR1583559A (en) 1969-11-14
AT289079B (en) 1971-04-13
AT289078B (en) 1971-04-13
BG15038A3 (en) 1975-06-10
YU33780B (en) 1978-05-15
ES368395A1 (en) 1971-05-01
NL136601C (en)
IE32373B1 (en) 1973-07-11
FR8162M (en) 1970-08-24
AT289080B (en) 1971-04-13
BG15037A3 (en) 1975-12-12
BG15040A3 (en) 1975-10-25
BE716647A (en) 1968-12-16
YU228974A (en) 1977-10-31
ES368399A1 (en) 1971-05-01
FI48922C (en) 1975-02-10
YU229374A (en) 1980-09-25
YU33776B (en) 1978-05-15
ES368398A1 (en) 1971-05-01
ES354823A1 (en) 1970-02-16
JPS5112613B1 (en) 1976-04-21
IE32373L (en) 1968-12-15
BG15041A3 (en) 1975-10-22
BG15042A3 (en) 1975-10-20

Similar Documents

Publication Publication Date Title
ES379739A1 (en) 1-(cyanophenoxy)-2-hydroxy-3-sec.-alkylamino-propanes
NO173998C (en) Analogous Procedures for Preparing Therapeutically Active Benzimidazole Derivatives
ES438931A1 (en) Compositions for treatment of cardiovascular conditions associated with overproduction of catecholamines
ES385523A1 (en) New pharmacologically active esters of n-(3-trifluoromethylphenyl)-anthranilic acid
ES368398A1 (en) Propanolamine derivatives
GB1362845A (en) Benzyl alcohol derivatives
BE622943A (en) Therapeutic compositions, containing emetine derivatives.
ES365335A1 (en) Aromatic amino ketones
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
SE7508516L (en) WAY TO PRODUCE NEW EBURNAMIN TYPE ALKALOID
ES372009A1 (en) Compositions comprising l-dopa
ES346192A1 (en) 6-chloro-2-(5-nitro-2-furyl) cinchoninic acid
GB1287433A (en) Pharmaceutical compositions
ES378186A1 (en) Azamorphinan compounds
ES346424A1 (en) Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them
ES363792A1 (en) 2-Sulfanilamido-3-Halogeno-Pyridines
GB1262140A (en) Pharmaceutical compositions
GB1276942A (en) Derivatives of chloramphenicol and thiamphenicol
GB1134516A (en) Antiviral compositions and treatment
GB1264128A (en)
ES340846A1 (en) Reserpine 3,5,3'-triiodothyroacetate
GB1159174A (en) Pharmaceutical Compositions
GB1183455A (en) 2,3,4,5,6 - Pentachlorobenzylidenamine Derivatives
ES343446A1 (en) Drug with hypertensive action on the base of 1-(3 4 - dimethoxy - 4-hydroxyphenyl)-2-monomethylaminoethanol
GB1192954A (en) Tartaric Acid-Histidine Salts